Prevention Study Introduces Alzheimer’s Retinal Imaging Eye Test

NeuroVision announced its participation in the landmark Anti-Amyloid Treatment in Asymptomatic Alzheimer’s (or “A4”) clinical trial.  They will be working with investigators at the University of California San Diego School of Medicine (UC San Diego) and the University of Southern California (USC). The purpose of the A4 study is to test whether a new investigational treatment called "solanezumab" can slow or prevent memory loss caused by Alzheimer’s. Beta-amyloid is the main suspect behind Al...
More

More Evidence Alzheimer’s is a Type of Diabetes

MEMORY PROBLEMS are an early sign of Alzheimer's. New research directly links these problems to sugar (glucose) deprivation in brain cells. In diabetes, a well-known Alzheimer's risk factor, sugar is blocked from entering cells. How likely does this make the Alzheimer's-sugar-diabetes triangle? (Philadelphia, PA) - One of the earliest signs of Alzheimer's disease is a decline in glucose levels in the brain. It appears in the early stages of mild cognitive impairment -- before symptoms of ...
More

Memory loss and other symptoms of dementia.

Dementia is a general term for a decline in mental ability severe enough to interfere with daily life. Memory loss is an example. Alzheimer's is the most common type of dementia. Dementia is not a specific disease. It's an overall term that describes a wide range of symptoms associated with a decline in memory or other thinking skills severe enough to reduce a person's ability to perform everyday activities. Alzheimer's disease accounts for 60 to 80 percent of cases. Vascular dementia, which ...
More

Validity of the Georgian Montreal Cognitive Assessment for the Screening of Mild Cognitive Impairment and Dementia

Montreal Cognitive Assessment (MoCA) test has been shown to be a reliable tool to detect mild cognitive impairment (MCI), however, no Georgian language version exists. The goal of this study is to determine the validity, reliability, and accuracy of Georgian version of MoCA in the evaluation of amnestic MCI (aMCI) and Alzheimer’s disease (AD). Montreal Cognitive Assessment was translated into Georgian language and was administered to healthy participants (HP) and patients with aMCI and AD...
More

ALZ i-Connect: A Novel Audiovisual Care Consultation for Caregivers

Currently, there is not enough time or staff in the physician’s office to provide education about Alzheimer’s disease for newly diagnosed patients and their family members. The Alzheimer’s Association Cleveland Area Chapter has implemented a novel approach for individuals to connect to helpful information about Alzheimer’s disease and related dementias while at the physician’s office. This project is being piloted at two memory assessment clinics of The Cleveland C...
More

Can We Help Care Providers Communicate More Effectively With Persons Having Dementia Living in Long-Term Care Homes?

Background:Effective communication between residents with dementia and care providers in long-term care homes (LTCHs) is essential to resident-centered care.Purpose:To determine the effects of a communication intervention on residents’ quality of life (QOL) and care, as well as care providers’ perceived knowledge, mood, and burden.Method:The intervention included (1) individualized communication plans, (2) a dementia care workshop, and (3) a care provider support system. Pre- and po...
More